| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | CA2267221A1 A gene related to migraine in man |
| 04/02/1998 | CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | CA2266315A1 Method of preventing acute rejection following solid organ transplantation |
| 04/02/1998 | CA2264567A1 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | CA2264546A1 Two human cathepsin proteins |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/01/1998 | EP0832978A2 Novel 3-dehydroquinate synthase |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832976A2 Thermostable DNA polymerase from bacillus pallidus |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832901A1 Antibodies to hepatitis G virus, and their diagnostic use to detect HGV, and as therapeutic agent |
| 04/01/1998 | EP0832251A1 Human ice homolog |
| 04/01/1998 | EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 04/01/1998 | EP0832243A1 Means for detecting and preventing hiv infection involving use of receptors or binding sites capable of interacting with gp120 |
| 04/01/1998 | EP0832242A1 Neutralizing conformational epitopes of chicken anemia virus |
| 04/01/1998 | EP0832238A1 Streptococcal heat shock proteins members of the hsp70 family |
| 04/01/1998 | EP0832237A1 Isospora suis vaccine |
| 04/01/1998 | EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
| 04/01/1998 | EP0832226A2 Ebnerin cloning of a secreted von ebner's gland protein |
| 04/01/1998 | EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832221A1 Bone stimulating factor |
| 04/01/1998 | EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832215A1 Fibroblast growth factor 11 |
| 04/01/1998 | EP0832193A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function |
| 04/01/1998 | EP0832189A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 04/01/1998 | EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
| 04/01/1998 | EP0832134A1 Anti-allergy bispecific molecules |
| 04/01/1998 | EP0832133A1 Monoclonal antibody detection of proteins on sperm related to fertility |
| 04/01/1998 | EP0832132A1 Lymphocyte chemoattractant factor and uses thereof |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832125A1 Human g-protein receptor hgber32 |
| 04/01/1998 | EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use |
| 04/01/1998 | EP0832105A1 Immunogenic peptides of prostate specific antigen |
| 04/01/1998 | EP0831922A2 Improved pharmaceutical compositions for gene therapy |
| 04/01/1998 | EP0831908A1 Methods of increasing cd4+ cell numbers in hiv-infected individuals |
| 04/01/1998 | EP0831907A1 Method for treating molluscum contagiosum resulting from hiv infection |
| 04/01/1998 | EP0831906A1 Treatment of t cell mediated autoimmune disorders |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831904A1 Treatment and diagnosis of prostate cancer |
| 04/01/1998 | EP0831900A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
| 04/01/1998 | EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
| 04/01/1998 | EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/01/1998 | EP0831714A1 Monospecific antibodies and methods using them |
| 04/01/1998 | EP0733208B1 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction |
| 04/01/1998 | EP0573510B1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 04/01/1998 | EP0507852B1 Gene deleted in colorectal cancer of humans |
| 04/01/1998 | CN1177982A System for the expression of heterologous antigens as fusion proteins |
| 04/01/1998 | CN1177980A Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/01/1998 | CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 03/31/1998 | US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide) |
| 03/31/1998 | US5734037 DNA encoding the human cytokine, interleukin-9 |
| 03/31/1998 | US5734035 Nematode vaccine |
| 03/31/1998 | US5734022 Antibodies to a novel mammalian protein associated with uncontrolled cell division |
| 03/31/1998 | US5733933 Methods and materials for the diagnosis and treatment of conditions such as stroke |
| 03/31/1998 | US5733878 Morphogen-induced periodontal tissue regeneration |
| 03/31/1998 | US5733790 CRF binding protein antibodies and assays using same |
| 03/31/1998 | US5733782 Methods and compositions for high protein production from non-native DNA |
| 03/31/1998 | US5733779 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
| 03/31/1998 | US5733778 Vaccines, medical diagnosis |
| 03/31/1998 | US5733757 Aldol condensations for antibodies |
| 03/31/1998 | US5733743 Genetic engineering |
| 03/31/1998 | US5733742 Polyclonal immunoglobulin fab fragments |
| 03/31/1998 | US5733738 Polypeptide-induced monoclonal receptors to protein ligands |
| 03/31/1998 | US5733549 Peptides including amino acid sequences selected from lipoprotein (a) and apolipoprotein (a), antibodies recognizing these amino acid sequences, and methods of determination using these antibodies |
| 03/31/1998 | US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 03/31/1998 | US5733542 Enhancing bone marrow engraftment using MSCS |
| 03/31/1998 | US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 03/31/1998 | US5733524 Screening for neuroprotective agents by administering them with infarct-producing amine compounds, then comparing responses in treated and untreated animals |
| 03/31/1998 | CA1339782C Fluorescent conjugates and biological diagnostic assay |
| 03/26/1998 | WO1998012564A1 Immunological composition for detection of bladder cancer and method of using same |
| 03/26/1998 | WO1998012561A1 Diagnostics for and mediators of inflammatory disorders |
| 03/26/1998 | WO1998012347A1 Rh blood group antigen compositions and methods of use |
| 03/26/1998 | WO1998012344A1 Human tumor necrosis factor receptor-like genes |
| 03/26/1998 | WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 03/26/1998 | WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 03/26/1998 | WO1998012326A1 Hedgehog interacting proteins and uses related thereto |
| 03/26/1998 | WO1998012325A1 Human gtp binding protein gamma-3 |
| 03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 03/26/1998 | WO1998012227A1 Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof |
| 03/26/1998 | WO1998012225A2 Process for producing a plasma protein-containing medicament |
| 03/26/1998 | WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
| 03/26/1998 | WO1998012223A1 Novel human interferon-inducible protein |
| 03/26/1998 | WO1998012220A2 Novel tumor proteins |
| 03/26/1998 | WO1998012204A1 Human b-cell translocation genes-2 and 3 |
| 03/26/1998 | WO1998011918A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
| 03/26/1998 | WO1998003653A3 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 03/26/1998 | WO1997049832A3 Method of identifying cytochrome p450 |
| 03/26/1998 | WO1997048724A3 Human metabotropic glutamate receptor |
| 03/26/1998 | WO1997040063A3 Pathogenic escherichia coli associated protein espa |
| 03/26/1998 | DE19723690A1 Use of Fc-gamma receptor antibodies |
| 03/26/1998 | CA2269092A1 Rh blood group antigen compositions and methods of use |
| 03/26/1998 | CA2266684A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
| 03/26/1998 | CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |